沃华医药(002107.SZ)发布前三季度业绩，归母净利润6399.5万元，增长179.34%

Core Insights - The company reported a revenue of 625 million yuan for the first three quarters of 2025, representing a year-on-year growth of 8.31% [1] - The net profit attributable to shareholders reached 63.995 million yuan, showing a significant year-on-year increase of 179.34% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 61.2711 million yuan, reflecting a year-on-year growth of 187.87% [1] - The basic earnings per share stood at 0.11 yuan [1]